After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Alnylam Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Alnylam Pharmaceuticals Inc is $33.02B. A total of 0.89 million shares were traded on the day, compared to an average of 954.61K shares.
In the most recent transaction, SCHULMAN AMY W sold 8,500 shares of ALNY for 240.00 per share on Jun 25 ’24. After the transaction, the Director now owns 8,436 company shares. In a previous transaction on Jun 25 ’24, Greenstreet Yvonne sold 8,301 shares at 230.99 per share. ALNY shares that Chief Executive Officer owns now total 80,534.
Among the insiders who sold shares, Garg Pushkal disposed of 2,103 shares on Jun 25 ’24 at a per-share price of $230.99. This resulted in the CMO & EVP Dev & Med Affairs holding 15,609 shares of ALNY after the transaction. In another insider transaction, Poulton Jeffrey V. sold 1,605 shares at $231.00 per share on Jun 25 ’24. Company shares held by the EVP, Chief Financial Officer now total 28,892.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALNY has a high of $257.97 and a low of $141.98.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was -$1.73, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.22.
